NASDAQ · Medical Distribution · USD
DataMEDS AI, Inc. (MEDS) Stock Analysis
DataMEDS AI, Inc. (MEDS) is a Medical Distribution stock listed on NASDAQ and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
MEDS Key Statistics
As of Sep 4, 2026Trading
- Open
- $0.98
- Previous Close
- $0.96
- Day's Range
- 0.92–1.04
- 52-Week Range
- 0.82–86.00
- Volume
- 311.50K
Valuation
- Market Cap
- $2.80M
- P/E Ratio
- unprofitable
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.35
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −48.30
Financials (FY)
- Revenue (FY)
- $23.34M+28.73%
- Net Income (FY)
- −$101.27M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 0.00%
- Shares Outstanding
- 3.06M
- 1-Year Return
- −98.66%
Dividend and dates
- Avg Volume
- 265.64K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
MEDS Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −95.42% |
| 2025 (partial year) | −89.50% |
As of September 4, 2026.
MEDS Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $23.34M | −$101.27M | −433.9% |
| 2024 | $18.13M | −$6.86M | −37.8% |
| 2023 | $0.00 | −$2.90M | — |
| 2022 | $32.78M | −$2.74M | −8.4% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $23.34M | −$6.43M | −$81.19M | −$101.27M | −433.9% |
| 2024 | $18.13M | $1.77M | −$6.15M | −$6.86M | −37.8% |
| 2023 | $0.00 | $0.00 | −$2.88M | −$2.90M | — |
| 2022 | $32.78M | $5.75M | −$3.42M | −$2.74M | −8.4% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
MEDS Valuation vs Medical Distribution Median
Median of 13 stocks| Metric | MEDS | Medical Distribution median | vs median |
|---|---|---|---|
| P/S ratio | 0.35 | 0.36 | 3% below |
| Profit margin | 0.00% | −4.03% | 4.0 pts above |
Medians across 13 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
YahooDataMEDS AI Q2 EPS $(7.13) Down From $(5.40) YoY, Sales $1.780M Down From $7.791M YoY
BenzingaDataMeds AI Reports Pharmacy Unit Corexa Health July Sales Of $600K+ With Annual Run Rate $7M+; Corexa Completes Registration With TrumpRx To Offer Patients Access To Oral GLP-1 Agonist Drugs
BenzingaDataMeds AI's Corexa Pharmacy Begins Direct-To-Consumer Distribution Of Tollovid And Galactovid
BenzingaDataMeds AI, Datavault AI Amend Definitive Agreement To Expand PharmacyChain Blockchain-Related Technology Licensing Relationship Beyond Pharmaceutical Distribution
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Distribution Stocks
McKesson Corporation
$105.86B
CORCencora, Inc.
$63.15B
CAHCardinal Health, Inc.
$57.49B
HSICHenry Schein, Inc.
$10.01B
AHGAkso Health Group
$726.49M
FOCLEDAP TMS S.A.
$190.70M
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B